Genedx Holdings Revenue Growth Rates (WGS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Genedx Holdings Corp   (NASDAQ: WGS)
 

WGS's Revenue Growth by Quarter and Year

Genedx Holdings 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WGS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 114.44
1st Quarter March 102.21
FY 216.65

WGSs Annual Revenue
Genedx Holdings 's Revenue in the fiscal year 2025 $ 427.17 millions
Genedx Holdings 's Revenue in the fiscal year 2024 $ 305.40 millions
Genedx Holdings 's Revenue in the fiscal year 2023 $ 202.01 millions
Genedx Holdings 's Revenue in the fiscal year 2022 $ 234.69 millions
Genedx Holdings 's Revenue in the fiscal year 2021 $ 212.20 millions




WGS Revenue second quarter 2026 Y/Y Growth Comment
Genedx Holdings Corp reported Revenue increase of 12.31% year on year in the second quarter 2026, to $ 114.44 millions, this is lower than Genedx Holdings Corp 's recent average Revenue increase of 19.32%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 93 other companies have achieved higher Revenue growth. While Genedx Holdings Corp ' s Revenue growth of 12.31% ranks overall at the positon no. 1533 in the second quarter 2026.


WGS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 27.09 % 66.31 % -5.7 %
3rd Quarter September - 51.67 % 44.25 % -36.01 %
2nd Quarter June 12.31 % 45.68 % 46.46 % 32.04 %
1st Quarter March 18.19 % 38.57 % 44.67 % -20.02 %
FY   - 39.88 % 51.18 % -

Financial Statements
Genedx Holdings 's second quarter 2026 Revenue $ 114.44 millions WGS's Income Statement
Genedx Holdings 's second quarter 2025 Revenue $ 101.90 millions Quarterly WGS's Income Statement


WGS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 4.93 % 25.22 % 8.62 %
3rd Quarter September - 14.36 % 9.84 % 11.52 %
2nd Quarter June 11.97 % 17.83 % 12.08 % 10.71 %
1st Quarter March -16.41 % -10.11 % 7.88 % -29.68 %
FY (Year on Year)   - 39.88 % 51.18 % -


Back to WGS Growth rate Comparisons >> Back to WGS Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #94
Healthcare Sector #254
Overall #1533

Revenue Y/Y Growth Statistics
High Average Low
51.18 % 19.32 % -13.93 %
(Dec 31 2024)   (Dec 31 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #94
Healthcare Sector #254
Overall #1533
Revenue Y/Y Growth Statistics
High Average Low
51.18 % 19.32 % -13.93 %
(Dec 31 2024)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Genedx Holdings 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
130.13 % 8.03 % -35.48 %
(Sep 30 2022)  


WGS's II. Quarter Q/Q Revenue Comment
Genedx Holdings Corp achieved in the II. Quarter 2026 above company average sequential Revenue rise of 11.97%, to $ 114.44 millions, from $102.21 millions in the first quarter.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Genedx Holdings 's Revenue growth quarter on quarter, overall rank is 736.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #121
Overall #736
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #121
Overall #736
Revenue Q/Q Growth Statistics
High Average Low
130.13 % 8.03 % -35.48 %
(Sep 30 2022)  


WGS's II. Quarter Q/Q Revenue Comment
Genedx Holdings Corp achieved in the II. Quarter 2026 above company average sequential Revenue rise of 11.97%, to $ 114.44 millions, from $102.21 millions in the first quarter.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Genedx Holdings 's Revenue growth quarter on quarter, overall rank is 736.


Genedx Holdings 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 455.45 $ 442.91 $ 427.17 $ 401.11 $ 361.41
Y / Y Revenue Growth (TTM) 26.02 % 34.43 % 39.87 % 50.2 % 48.44 %
Year on Year Revenue Growth Overall Ranking # 361 # 271 # 55 # 24 # 63
Seqeuential Revenue Change (TTM) 2.83 % 3.68 % 6.5 % 10.98 % 9.7 %
Seq. Revenue Growth (TTM) Overall Ranking # 1537 # 1400 # 262 # 948 # 475


Cumulative Revenue growth Comment
Assuming the Genedx Holdings 's fiscal year would have ended in Jun 30 2026, Genedx Holdings would have reprted above average annual Revenue rise of 26.02% year on year, of $ 455 millions.
This marks a slow-down of the companys growth trends and from the 34.43% improvement in Mar 31 2026.

In the Healthcare sector 91 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 271 to 361.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 92
Overall # 361

Revenue TTM Y/Y Growth Statistics
High Average Low
51.18 %
 19.32 %
-13.93 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 255
S&P 500 # 1537
Cumulative Revenue growth Comment
Assuming the Genedx Holdings 's fiscal year would have ended in Jun 30 2026, Genedx Holdings would have reprted above average annual Revenue rise of 26.02% year on year, of $ 455 millions.
This marks a slow-down of the companys growth trends and from the 34.43% improvement in Mar 31 2026.

In the Healthcare sector 91 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 271 to 361.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 92
Overall # 361

Revenue TTM Y/Y Growth Statistics
High Average Low
51.18 %
19.32 %
-13.93 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 255
S&P 500 # 1537




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
WGS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions
Anika Therapeutics Inc 19.18%$ 19.176 millions
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions
Camp4 Therapeutics Corporation18.84%$ 18.838 millions
Lensar Inc 18.37%$ 18.371 millions
Immunocore Holdings Plc18.34%$ 18.336 millions
Innovage Holding Corp 18.31%$ 18.307 millions
Koru Medical Systems Inc 18.15%$ 18.153 millions
Clearpoint Neuro Inc 18.07%$ 18.068 millions
Avita Medical Inc 17.83%$ 17.830 millions
Xencor Inc17.46%$ 17.458 millions
Logicmark Inc17.39%$ 17.387 millions
Ensign Group Inc17.33%$ 17.325 millions
Medpace Holdings Inc 17.24%$ 17.242 millions
Geron Corporation17.22%$ 17.220 millions
Si bone inc 17.16%$ 17.159 millions
Cvrx inc 16.77%$ 16.766 millions
Regeneron Pharmaceuticals Inc 16.73%$ 16.735 millions


About Genedx Holdings Revenue Growth Rates (WGS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Genedx Holdings Corp (CIK 1818331).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-051878
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Genedx Holdings Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.